Case Studies
Introducing Origin-1: a platform for de novo antibody design against zero-prior epitopes
ABS-201 Case Study
Cracking HIV’s Code with AI-Designed Antibodies
ABS-101 Case Study: Potential best-in-class TL1A mAb for IBD
ABS-201 Case Study: Potential best-in-class antibody targeting the prolactin receptor for the treatment of androgenic alopecia
